We use cookies to create the best experience for you. Keep on browsing if you are OK with that, or find out how to manage cookies.

Myeloproliferative Disorders - Essay Example

Comments (0)
Summary
Myeloproliferative disorders (MPDs) are a heterogeneous group of disorders, which originate from a multipotent progenitor. These clonal haematopoietic stem cell disorders present with the features of Polycythemia Vera (PV), Essential Thrombocythemia (ET) and Idiopathic Myelofibrosis (IM) (Jones 2005; Tefferi 2006; Campbell 2006; Kralovics 2005; Jamieson 2006; Goldman 2005; Aaronson 2002; Goerttler 2005; Steensma 2005; Passegue 2003; Jamieson 2004; Huntly 2004; Jamieson 2004; Passague 2004; Varidman 2002)…
Download full paper
GRAB THE BEST PAPER

Extract of sample
Myeloproliferative Disorders

Download file to see previous pages... In 2005, similarity in the major disease groups of MPDs got some explanation when Janus Kinase 2 V617F (JAK2- V617F) which in fact represents a G to T somatic mutation of JAK2 at nucleotide 1849, in exon 14, which eventually end up in the substitution of valine to phenylalanine at codon 617 (Tefferi 2006).
Apparently, it seems that all group members of MPDs contain JAK2-V617F in equal proportion in all patients, persistently; which raises the question of capturing all disorders in the group through a single mutation, how is it possible But this is not the case!
In fact, various diseases of the group carry this mutation in their genetic materials with different proportions in different patients; moreover, these diseases do not constantly carry this mutation as a universal principle. ...
Various researchers have got the evidence to describe that the proportion of the patients with one of the three diseases of MPDs carry JAK2-V617F in different proportions and among these diseases PV is the disease which carries it to the maximum level. According to Tefferi (Tefferi 2006), almost all patients with PV carry the mutation while in the remaining two diseases, ET and IM, about half of the patients each in the two groups carry JAK2-V617F. While Jones et al (Jones 2005) gave could capture lower frequency of the mutation in these diseases, like: 81 percent of the patients with PV could show JAK2-V617F, 43 percent with IM and 41 percent with ET were able to reflect the mutated genetic material.

This non-consistent behaviour of the mutated genetic material demands some further exploration in this area. One possible explanation in the favour of single mutation with multiple diseases still exists and which is related to sensitivity and specificity of the tests capturing the findings, which support JAK2-V617F. There are chances that mutation is present in the disease groups belonging to MPDs but the available tests are not efficient enough to detect that. For this answer we need to wait for the availability of refined testing system.

At the same time it seems obvious that some other mechanisms are also operating in differentiating the progenitor to different diseases. Whether these mechanisms are timed before, after or at the same time as the mutation develops; it is to be answered.

Jamieson et al (Jamieson 2006) found through their study that: in samples of PV patients, the cells with haematopoietic stem cells phenotype produced JAK2-V617F which in ...Download file to see next pagesRead More
Comments (0)
Click to create a comment
CHECK THESE SAMPLES - THEY ALSO FIT YOUR TOPIC
Haematology
Initial damage to the endothelial wall promotes the expression of von Willebrand factor (vWF) on the damaged cells at the site of injury. These factors acts like a glue to adhere the fast moving platelets with the strength sufficient enough to withstand the streamline force of the blood.
14 Pages(3500 words)Essay
Discuss the classification of the leukaemias and how this can be used to help treat this group of disorders. Use specific types
Leukemia occurs due to malignant transformation of blood forming cells which are known as hematopoietic cells. The leukemic cells primarily proliferate in the lymphoid tissues and the bone marrow and then migrate to the peripheral blood. Due to abnormal proliferation, they interfere with the normal hematopoiesis and immunity in both the lymphoid tissue and the bone marrow.
7 Pages(1750 words)Essay
Haematology and immunology
They are also known as myeloproliferative neoplasms (MPNs) and include a number of diseases like: Essential thrombocytosis It occurs when platelets in the blood tissue are produced in large numbers than normal and cause the blood to thicken. The blood flow then slows and could be harmful to health as it could lead to stroke and cardiac arrest.
6 Pages(1500 words)Essay
Disorders
In short he was an ideal American: rich, successful and handsome. It made the film’s narrative terrifyingly engaging because as he lived his perfect life, Bateman was also living a darker version of himself, a persona with spectacular anger issues, killing people at will.
3 Pages(750 words)Essay
Case Study Discuss the pathpyysiology of Myelofibrosis
The initiating pathologic event takes place in the bone marrow that displays features of dysplastic megakaryocyte hyperplasia, proliferation of granulocytic cell lineage, and reticulin and/or collagen fibrosis. The disease presentation clinically happens in one of the three ways, de novo, as primary myelofibrosis (PMF) or preceded by polycythemia vera known as post polycythemia vera (post-PV MF) or heralded by essential thromocythemia (Post-ET MF).
16 Pages(4000 words)Essay
Case Study Discuss the pathpyysiology of Myelofibrosis
Myelofibrosis is a complicated syndrome, with over twenty synonyms and a variety of presentations (Lewis, 1985). Some of the names associated with the syndrome include Agnogenic Myeloid Metaplasia, and Myelofibrosis with Myeloid
8 Pages(2000 words)Essay
Cllinical Skils in haematology and bone marrow transplantion Nursing Module
This is a unit with 29 beds and 6 bone marrow transplant beds. During clinical work, the patients that I handle have haematological disorders, and many patients end up having marrow failure, and they need to be treated with bone marrow transplants. Many patients have a
12 Pages(3000 words)Essay
Eating Disorders
However, exercise cannot achieve the required healing to eating disorders. Specific treatments should be considered when dealing with eating disorders. Many treatments for eating disorders are psychological based treatments. In
1 Pages(250 words)Essay
Movement Disorders
Some of these indicators include bradykinesia, tremors, and intermittent rigidity. Jim began to experience the symptoms after being prescribed an antihypertensive drug that is known to be associated with DIP (Rao, Hofmann, &
2 Pages(500 words)Essay
Gleevac
Its molecular formula is presented as C29H31N7O • CH4SO3 with molecular weight 589.7. The structural formula is as figure 1[11] Chemical designation is 4-[(4-methyl-1-poperazinyl) methyl]-N-[4-methyl-3-[[4-(3-pyridinyl)-2-pyrimidinyl] amino]-phenyl] benzamide
12 Pages(3000 words)Essay
Let us find you another Essay on topic Myeloproliferative Disorders for FREE!
Contact us:
+16312120006
Contact Us Now
FREE Mobile Apps:
  • About StudentShare
  • Testimonials
  • FAQ
  • Blog
  • Free Essays
  • New Essays
  • Essays
  • The Newest Essay Topics
  • Index samples by all dates
Join us:
Contact Us